InvestorsHub Logo

mastiffsforlife

08/07/17 10:52 AM

#28926 RE: Simple Steve #28922

If Advaxis feels that the data from the combo trial with Merck continues to improve and it's worth presenting at a medical conference. Then there should be no reason that the two are not negotiating a deal right now. Otherwise what's the point!!!!

Easymoneyman00

08/07/17 8:16 PM

#28986 RE: Simple Steve #28922

Really? Just enough to keep trials going? Isn't that the whole idea? Simple Steve says it all... lol.